Health Economics and Market Dynamics Training Course | EuroQuest International Training

Health economics sits at the point where clinical value meets scarce resources, and the people who allocate those resources rarely have enough of them. This course examines how demand and supply behave in health markets, how interventions are valued against one another, and how financing and reimbursement rules steer what patients actually receive. It treats economic evaluation as a practical discipline: measuring costs and consequences, expressing benefit in quality-adjusted terms, and translating that evidence into defensible funding decisions.

Participants work through the core evaluation methods used by payers and health technology assessment bodies, from cost-effectiveness and cost-utility analysis to broader cost-benefit reasoning. The content connects these methods to the market forces around them, including insurer behavior, provider competition, pricing negotiation, and the policy reforms that reshape incentives. The aim is fluency in the vocabulary and logic that ministries of health, insurers, and manufacturers use when they argue over what a treatment is worth.

Why this matters

Global health spending has grown faster than most economies can comfortably absorb, and aging populations, chronic disease, and high-cost specialty medicines keep pressure on every budget holder. Agencies such as NICE in England, IQWiG in Germany, and Canada's CADTH now gate access to new therapies using explicit cost-effectiveness thresholds, so the same molecule can be reimbursed in one country and refused in another purely on economic grounds. Understanding why a QALY carries a monetary ceiling, or how a DALY frames disease burden in low-income settings, has become essential for anyone negotiating price, coverage, or formulary placement.

These decisions no longer belong only to economists. Clinicians defending a service line, insurers designing benefit tiers, and manufacturers building a value dossier all draw on the same evidence base. As systems shift toward paying for outcomes instead of volume, the ability to read and challenge an economic model matters as much as reading a trial result. Related work on implementing value-based healthcare models shows how these economic principles translate into contracting and delivery, and this course supplies the analytical foundation that such reform depends on.

What you will be able to do afterwards

When the sessions wrap up, you will be able to read and apply the economics that drive health systems:

Explain demand, supply, and market failure in health care markets.
Build cost-effectiveness, cost-utility, and cost-benefit assessments.
Evaluate health technology assessment submissions and modeling.
Compare public and private financing on access and equity.
Assess pricing and reimbursement mechanisms across markets.
Lead the economic case for value-based care with stakeholders.

Course outline

Unit 1: Introduction to Health Economics

Health economics versus general microeconomics.
Scarcity and information asymmetry in health care.
Moral hazard and supplier-induced demand in care.
Demand, supply, subsidy, insurance, and regulation.

Unit 2: Healthcare Financing and Insurance Models

Tax-funded, social insurance, and out-of-pocket financing.
Risk pooling, adverse selection, and copayment design.
Beveridge and Bismarck models across Europe and Asia.
Access, equity, and catastrophic health spending.

Unit 3: Cost-Effectiveness and Resource Allocation

Cost-effectiveness, cost-utility, and cost-benefit analysis.
Cost-effectiveness thresholds and opportunity cost.
Decision-tree and Markov modeling, QALY, and DALY.
NICE case studies in cost-effectiveness coverage.

Unit 4: Market Forces and Policy Impact

Competition in provider and pharmaceutical markets.
Reference, value-based, and managed-entry pricing.
Formulary controls, generic and biosimilar substitution.
Balance of equity, efficiency, and innovation in regulation.

Unit 5: Global Trends and Future Directions

Health expenditure trends and sustainability challenges.
Emerging markets: digital health and gene therapies.
Value-based care and outcomes-based payment.
Market shifts and reimbursement change.

How the course is delivered

Teaching combines expert-led discussion, documented economic-evaluation case studies, and guided walk-throughs of cost-effectiveness models, financing structures, and reimbursement decisions. Participants weigh real appraisals — how a payer valued a new therapy, how a reform shifted access — and see where economic reasoning changed the outcome.

Who should attend

Professionals working where health meets money will find it directly useful:

Health policy analysts, ministry officials, and regulators shaping coverage and financing decisions.
Payer and insurance staff working on benefit design, formulary, and reimbursement.
Pharmaceutical and medical device market access, pricing, and health economics teams.
Hospital and health system managers responsible for resource allocation and service planning.
Consultants and researchers building the economic case for health interventions.

About EuroQuest International Training

Launched in 2015, EuroQuest International Training is directed from the Slovak capital, Bratislava, and keeps 1,000+ courses on its schedule alongside more than 15,000 professionals developed. Learning is offered in Paris, Istanbul, Geneva, London, Dubai, Vienna, and Barcelona, placing analysts and policy staff within reach of an expert-led classroom.

Frequently asked questions

Do I need an economics degree to keep up?

No. Core ideas such as demand, supply, and opportunity cost are built up from first principles, so health managers, policymakers, and payers without formal economics training follow comfortably while quantitatively minded participants go deeper.

Which methods and bodies does the course cover?

It works through cost-effectiveness, cost-utility, and cost-benefit assessment, QALY and DALY measures, and pricing and reimbursement mechanisms, treating health-technology-assessment bodies such as NICE as illustrative subject matter rather than a single prescribed model.

What certificate results, and is any of this investment advice?

Completion brings a EuroQuest certificate of completion for the material you studied. None of it constitutes financial, investment, or pricing guidance; the teaching is educational, and the certificate carries no formal standing.

Related courses

Register for this course

Join a session to make sharper, evidence-based calls in health markets. Contact our advisors for scheduling, venue choices, and enrollment for your group.